HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

U Bacher Selected Research

Therapeutics

3/2013Toxicity-reduced, myeloablative allograft followed by lenalidomide maintenance as salvage therapy for refractory/relapsed myeloma patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


U Bacher Research Topics

Disease

5Multiple Myeloma
03/2013 - 06/2008
3Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2016 - 04/2011
3Philadelphia Chromosome
03/2014 - 03/2005
3Neoplasms (Cancer)
09/2013 - 08/2008
2Lymphoma (Lymphomas)
02/2015 - 01/2014
2Chromosome Aberrations (Chromosome Abnormalities)
07/2014 - 03/2010
2Residual Neoplasm
03/2014 - 08/2008
1Primary Myelofibrosis (Myelosclerosis)
11/2017
1Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
01/2016
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
03/2014
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2014
1BCR-ABL Negative Atypical Chronic Myeloid Leukemia (Leukemia, Myeloid, Philadelphia Negative)
09/2013
1Peripheral Nervous System Diseases (PNS Diseases)
03/2013
1Fatigue
03/2013
1Neutropenia
03/2013
1Thrombocytopenia (Thrombopenia)
03/2013
1Pathologic Complete Response
10/2012
1Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
10/2012
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
04/2011
1Mannose-Binding Protein Deficiency
01/2010
1Infections
01/2010
1Lymphoproliferative Disorders (Lymphoproliferative Disorder)
08/2008
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
03/2005
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
06/2004

Drug/Important Bio-Agent (IBA)

3Lenalidomide (CC 5013)FDA Link
01/2016 - 02/2010
2Imatinib Mesylate (Gleevec)FDA Link
03/2014 - 03/2005
2Tyrosine Kinase InhibitorsIBA
03/2014 - 03/2010
1Thrombopoietin ReceptorsIBA
11/2017
1CalreticulinIBA
11/2017
1S 0139 (97-139)IBA
07/2014
1DNA (Deoxyribonucleic Acid)IBA
02/2014
1Carrier Proteins (Binding Protein)IBA
09/2013
1Rituximab (Mabthera)FDA Link
10/2012
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
08/2012
1NucleophosminIBA
04/2011
1HLA-DR Antigens (HLA-DR)IBA
02/2010
1Mannose-Binding Lectin (Mannan-Binding Lectin)IBA
01/2010
1fludarabineIBA
06/2008
1Melphalan (Alkeran)FDA LinkGeneric
06/2008
1Interferon-alpha (Interferon Alfa)IBA
03/2005
1Genetic Markers (Genetic Marker)IBA
06/2004

Therapy/Procedure

3Stem Cell Transplantation
11/2017 - 08/2008
3Transplantation
02/2015 - 08/2008
2Homologous Transplantation
11/2017 - 03/2014
2Cell Transplantation
03/2014 - 01/2014
2Hematopoietic Stem Cell Transplantation
10/2011 - 06/2008
1Autologous Transplantation
01/2016
1Therapeutics
03/2013
1Drug Therapy (Chemotherapy)
10/2012
1Salvage Therapy
02/2010